Strep Throat Treatment Market size is expected to reach USD 3 billion by the end of 2036, growing at a CAGR of 5% during the forecast period, i.e., 2024-2036. In the year 2023, the industry of strep throat treatment was USD 2 Billion. The rise in several deaths from rheumatic heart disease mainly in industrial fields will exponentially help the strep throat treatment market to grow in the expected CAGR. Over 288 348 people die from rheumatic heart disease each year, the majority of them reside in low- or middle-income nations. Recurrent strep infections can make some people's immune systems respond negatively to bodily tissues, leading to heart valve inflammation and scarring. This is the condition known as rheumatic fever and this fever can take away lives.
Another reason to propel the strep throat treatment market by the end of 2036 is the increasing prevalence of streptococcus bacteria across the world. Some European nations (the United Kingdom, France, Ireland, the Netherlands, and Sweden) have reported a rise in invasive Group A streptococcal (iGAS) cases among children under the age of ten in 2022, especially since September. In the same time frame, reports of multiple iGAS-related deaths in children under 10 have also been made, notably from France, Ireland, and the UK. The number of pediatric iGAS cases reported in France and the UK has been several times greater than pre-pandemic values for the same time frame. The most frequent cause of bacterial pharyngitis in children of school age is GAS bacteria. Scarlet fever, a fine, red rash, and moderate symptoms such as headache, sore throat, and fever are typically the result of gas infections. The inflammation and scarring of heart valves brought on by rheumatic fever subsequently lead to rheumatic heart disease.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2036 |
|
CAGR |
∼5% |
|
Base Year Market Size (2023) |
~USD 2 Billion |
|
Forecast Year Market Size (2036) |
~USD 3 Billion |
|
Regional Scope |
|
Diagnosis (Antibody Test, Physical Examination, Throat Culture)
The antibody test segment will grow the most by the forecast period and will hold almost 58% in the strep throat treatment market because of the rising use of antibody tests to diagnose strep throat. Approximately 10 percent of school-age children regularly carry these bacteria in their upper respiratory tracts and throats without exhibiting any symptoms, and with time, they will become somewhat immune to them. Children were presumably less exposed to microorganisms at home during the COVID-19 pandemic than they were outside, so their immune systems are possibly not as powerful against these infections. Certain children are probably going to be more prone to infection in the absence of this exposure. The organism possesses several characteristics that encourage infection and enable the bacteria to penetrate, colonize, and persist in many tissues, resulting in this broad spectrum of disorders in various body areas.
Disease Type (Acute Strep Throat, Pharyngitis, Tonsillitis, Laryngitis)
The acute strep throat segment will have superior growth during the forecast period and will hold around 64% of the revenue share of the strep throat treatment market owing to the increasing cases of acute strep throat globally. Between 14,000 and 25,000 instances of invasive group A strep illness have been reported annually in the US during the last five years. Between 1,500 and 2,300 persons have lost their lives to invasive group A strep per year over the past five years. But because it's an aggressive opportunistic disease, it kills over 500,000 people globally. Close contact with an infected person can spread the infection through coughing, sneezing, or touching a wound. To mitigate or neutralize the effects of the bacterial toxin generated, intravenous fluid and electrolyte treatment is part of the supportive clinical management of severe isolated GAS infections.
Our in-depth analysis of the global strep throat treatment market includes the following segments:
|
Diagnosis |
|
|
End-Use Industry |
|
|
Route of Administration |
|
|
Treatment Type |
|
|
Disease Type |
|
|
Distribution Channel |
|
North American Market Statistics
The strep throat treatment market in the North America region will have the biggest growth during the forecast period with a revenue share of around 38%. This growth will be noticed owing to the rising advancement in technology in this region. However, Canada is fast becoming a hub for technology within North America, thus the US isn't the only place where technology innovation comes from. Our recent study of over 1,600 technology professionals confirmed the region's technological prowess, with respondents ranking North America as the world's most technologically advanced region.
European Market Analysis
The strep throat treatment market in the Europe region will also encounter huge growth during the forecast period and will hold the second position owing to the rising attainability of healthcare in this region. The Sustainable Development Goals (SDGs) objective 3.8, which calls for universal health coverage by 2030, is not likely to be achieved by the globe on track. Since 2015, progress in expanding access to health services has stalled, and since 2000, the share of the population that had to pay catastrophic amounts out of pocket for medical care has risen steadily. Most countries and all regions of the world follow this worldwide pattern.
Author Credits: Radhika Gupta, Shivam Bhutani
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?